CIK 0001488039 · Non-accelerated filer<br>Smaller reporting company
ATOSSA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ATOS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 264753208
- Phone
- 206.588.0256
- Business address
- 1448 NW MARKET STREET, SUITE 500, SEATTLE, WA, 98107
- Former names
- ATOSSA GENETICS INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 1,500 shares at $0.33 ($495)
- 4 Open-market buy Director bought 15,000 shares at $0.37 ($5,550)
- 4 Open-market buy President & CEO bought 15,000 shares at $0.37 ($5,550)
- 4 Open-market buy President & CEO bought 15,000 shares at $0.53 ($7,950)
- 4 Open-market buy Director bought 15,000 shares at $0.53 ($7,950)
- 4 Open-market buy Director bought 50,000 shares at $0.20 ($10,000)
- 4 Open-market buy President & CEO bought 50,000 shares at $0.20 ($10,000)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 5,400 shares at $1.30 ($7,020)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 6 of 9 · 161 filings